East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more East Resources Acquisition Charts. Click Here for more East Resources Acquisition Charts.](/p.php?pid=staticchart&s=N%5EERES&p=8&t=15)
eResearchTechnology, Inc. to Announce First Quarter Results on
April 21, 2004
PHILADELPHIA, April 13 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc.
(eRT) , a leading provider of centralized electrocardiographic (ECG) collection
and interpretation services, announced today that it will release its first
quarter results for the period ended March 31, 2004 on Wednesday, April 21, 2004
after the market closes. After the release, the company will host a conference
call to discuss these results.
The conference call will take place at 4:45 PM EDT later that day. Interested
participants should call 877-715-5321 when calling within the United States or
973-582-2785 when calling internationally. There will be a playback available
as well. To listen to the playback, please call 877-519-4471 when calling
within the United States or 973-341-3080 when calling internationally. Please
use pass code 4673109 for the replay.
This call is being webcast by ViaVid Broadcasting and canalso be accessed at
eRT's web site at http://www.ert.com/. The webcast may also be accessed at
ViaVid's website at: http://www.viavid.net/detailpage.aspx?sid=00001AF9. The
webcast can be accessed until May 21, 2004 on either site.
Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a
provider of technology and services to the pharmaceutical, biotechnology and
medical device industries on a global basis. The company is a market leader in
providing centralized core-diagnostic electrocardiographic (ECG) technology and
services to evaluate cardiac safety in clinical development. The company is
also a leader in providing technology and services to streamline the clinical
trials process by enabling its customers to automatethe collection, analysis,
and distribution of clinical data in all phases of clinical development.
Statements included in this release may constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
Such statements involve a number of risks and uncertainties such as competitive
factors, technological development, market demand, and the company's ability to
obtain new contracts and accurately estimate net revenues due to variability in
size, scope and duration of projects, and internal issues in the sponsoring
client. As a result, actual results may differ materially from any financial
outlooks stated herein. Further information on potential factors that could
affect the company's financial results can be found in the company's Reports on
Form 10-K filed with the Securities and Exchange Commission.
DATASOURCE: eResearchTechnology, Inc.
CONTACT: Joan Sterlacci, eResearchTechnology, Inc., +1-908-203-6473; or
Matt Hayden, Hayden Communications, +1-858-456-4533, for eResearchTechnology
Web site: http://www.ert.com/